Skip to main content
logo
Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
99.88
-1.03 (-1.02%)
Feb 11, 2026, 4:00 PM EST - Market closed

Mirum Pharmaceuticals Revenue

Mirum Pharmaceuticals had revenue of $133.01M in the quarter ending September 30, 2025, with 47.17% growth. This brings the company's revenue in the last twelve months to $471.79M, up 53.66% year-over-year. In the year 2024, Mirum Pharmaceuticals had annual revenue of $336.89M with 80.76% growth.

Revenue (ttm)
$471.79M
Revenue Growth
+53.66%
P/S Ratio
10.45
Revenue / Employee
$1,328,997
Employees
355
Market Cap
5.98B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024336.89M150.51M80.76%
Dec 31, 2023186.37M109.31M141.85%
Dec 31, 202277.06M57.92M302.66%
Dec 31, 202119.14M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
PTC Therapeutics1.78B
Caris Life Sciences649.06M
Protagonist Therapeutics209.22M
Rhythm Pharmaceuticals174.33M
ImmunityBio82.56M
Kymera Therapeutics43.74M
Crinetics Pharmaceuticals1.54M
Revenue Rankings

MIRM News

More News